DUBLIN--(BUSINESS WIRE)--The "Global Risk-based Monitoring Software Market Analysis 2020" report has been added to ResearchAndMarkets.com's offering.
The Global Risk-based Monitoring Software market is expected to reach $652.40 million by 2026 growing at a CAGR of 15.3% from 2019 to 2026.
Risk-based monitoring (RBM) software is a clinical trial-monitoring method that fulfills regulatory necessities. It employs various tools, platforms and dashboards to identify signals, which indicate potential issues with trial conduct, safety, data integrity, compliance and enrollment.
Factors such as the growing number of outsourcing activities of clinical trials to CROs and increasing usages of software for the rising number of clinical trials are driving the growth of the market. However, the high implementation cost is restraining the growth of the market.
Based on the component, the software segment is anticipated to grow at a significant rate during the forecast period owing to increasing R&D expenditure in the life science and clinical research industries, an increasing number of clinical trials, and rising customer base.
The key vendors mentioned are MasterControl, Veeva Systems, Techsol Corporation, Parexel, Oracle, ArisGlobal, MedNet Solutions, Bio-Optronics, MaxisIT, Covance, IBM Corporation, Forte Research Systems, ERT, DSG, OpenClinica, CRF Health, Anju Software, DATATRAK, Bioclinica, and Medidata Solutions.
Key Questions Answered in this Report:
- How this market evolved since the year 2018
- Market size estimations, forecasts and CAGR for all the segments presented in the scope
- Key Market Developments and financials of the key players
- Opportunity Analysis for the new entrants
- SWOT Analysis of the key players
- Fastest growing markets analyzed during the forecast period
Key Topics Covered:
1 Market Synopsis
2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources
3 Market Dynamics
3.1 Drivers
3.2 Restraints
4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Risk-based Monitoring Software Market, By Component
5.1 Introduction
5.2 Software
5.3 Services
6 Global Risk-based Monitoring Software Market, By Type
6.1 Introduction
6.2 Site RBM Software
6.3 Enterprise RBM Software
7 Global Risk-based Monitoring Software Market, By Application
7.1 Introduction
7.2 Medical Equipment
7.3 Clinical Trials
7.4 Biopharmaceutical
8 Global Risk-based Monitoring Software Market, By Delivery Mode
8.1 Introduction
8.2 Web-based (On-demand)
8.3 Licensed Enterprise (On-premise)
8.4 Cloud-based (SaaS)
9 Global Risk-based Monitoring Software Market, By End User
9.1 Introduction
9.2 Pharmaceutical & Biopharmaceutical Companies
9.3 Medical Device Companies
9.4 Contract Research Organizations (CROs)
10 Global Risk-based Monitoring Software Market, By Geography
10.1 Introduction
10.2 North America
10.3 Europe
10.4 Asia Pacific
10.5 South America
10.6 Middle East & Africa
11 Strategic Benchmarking
12 Vendors Landscape
12.1 MasterControl
12.2 Veeva Systems
12.3 Techsol Corporation
12.4 Parexel
12.5 Oracle
12.6 ArisGlobal
12.7 MedNet Solutions
12.8 Bio-Optronics
12.9 MaxisIT
12.10 Covance
12.11 IBM Corporation
12.12 Forte Research Systems
12.13 OpenClinica
12.14 CRF Health
12.15 Anju Software
12.16 DATATRAK
12.17 Bioclinica
12.18 Medidata Solutions
For more information about this report visit https://www.researchandmarkets.com/r/jq07pt
